Is Fixed Duration Therapy the New Standard?
Update: 2025-11-19
Description
Patient advocate, Michele Nadeem Baker, hosts Boyu Hu, MD, Director of Lymphoma and Chronic Lymphocytic Leukemia at the Huntsman Cancer Institute at the University of Utah for a discussion on fixed duration treatment.
Comments
In Channel



